28 completed, 12 recruiting, 8 unknown, 2 active not recruiting. 54 Phase 2, 7 Phase 1, 2 Phase 3.
Follow CBD: new trials by email Literature Review of CBD trials Research Report on CBD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome Epidiolex 100 mg/mL Oral Solution - Sturge - Weber Syndrome (SWS) | Phase 2 | Recruiting | Johns Hopkins University | 10 | 2026-09-17 | 2026-10-02 |
| Cannabidiol for Pain Relief of Patients With End-stage mCRPC Cannabidiol, Placebo - Metastatic Castration Resistant Prostate Cancer (mCRPC) | Phase 2 | Recruiting | Regionshospital Nordjylland | 58 | 2026-06-12 | 2026-09-16 |
| CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury CBD - Supra-sacral Spinal Cord Injury, Spinal Cord Injury | Phase 2 | Recruiting | University of Wisconsin, Madison | 20 | 2026-02-13 | 2026-09-16 |
| Cannabis (THC vs. CBD) in Multiple Sclerosis THC, CBD - Multiple Sclerosis | Phase 2 | Recruiting | University of Calgary | 30 | 2025-12-05 | 2026-09-15 |
| Study of Cannabidiol and Neuroimaging on Stress Cannabidiol, Placebo - Early Life Adversity, Trauma | Phase 1 / Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 160 | 2025-10-29 | 2026-09-10 |
| Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors Biospecimen Collection, Cannabidiol, Dronabinol - Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy | Phase 2 | Recruiting | City of Hope Medical Center | 120 | 2025-10-03 | 2025-12-05 |
| Warrior CARE: Cannabis Behavioral Health Tetrahydrocannabinol, Cannabidiol, Placebo - Post Traumatic Stress Disorder, Cannabis Use | Phase 1 / Phase 2 | Recruiting | Wayne State University | 500 | 2025-09-22 | 2026-08-07 |
| Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms Cannabidiol 100 mg/ml, cannabidiol 300 mg/ml, Cannabidiol 400 mg/ml - Parkinson Disease | Phase 2 | Recruiting | Laboratorio Elea Phoenix S.A. | 88 | 2024-11-28 | 2024-12-05 |
| High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer Biospecimen Collection, BRC-001, Placebo Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Suspended | City of Hope Medical Center | 36 | 2024-08-26 | 2026-07-14 |
| PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product Cannabidiol, Placebo - Chronic Pain | Phase 2 | Active not recruiting | Staci Gruber, Ph.D. | 25 | 2024-06-27 | 2026-09-30 |
| The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis Cannabidiol Oil - Sleep Quality, Multiple Sclerosis | Phase 2 | Completed | Wageningen University | 16 | 2024-03-26 | 2026-09-25 |
| CBD for Individuals at Risk for Alzheimer's Disease Cannabidiol, Placebo - Mild Cognitive Impairment | Phase 2 | Recruiting | University of Colorado, Denver | 236 | 2024-01-19 | 2026-06-15 |
| Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis IHL-675A, Cannabidiol, Hydroxychloroquine - Rheumatoid Arthritis | Phase 2 | Terminated | Incannex Healthcare Ltd | 20 | 2023-11-22 | 2026-03-27 |
| Cannabidiol Medication Intervention Trial CBD, Placebo - Alzheimer Disease | Phase 2 | Recruiting | Sunnybrook Health Sciences Centre | 40 | 2023-09-27 | 2026-07-31 |
| Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV THC, CBD - HIV, Cannabis | Phase 2 | Recruiting | University of California, San Diego | 90 | 2023-09-01 | 2026-05-01 |
| Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial Cannabidiol, Placebo - Brain Injuries, Traumatic | Phase 2 | Completed | University of Colorado, Denver | 43 | 2023-04-11 | 2025-12-17 |
| Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults Cannabidiol Administered as Nantheia ATL5, Placebo - PTSD | Phase 2 | Recruiting | University of Nebraska | 140 | 2022-12-01 | 2026-09-17 |
| A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users cannabis 0 mg, placebo, Cannabis 20 mg,, Cannabis 50 mg - Cannabis | Phase 1 / Phase 2 | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 70 | 2022-07-22 | 2024-04-22 |
| Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy Cannabidiol, Placebo Administration, Quality-of-Life Assessment - Chemotherapy-Induced Peripheral Neuropathy, Malignant Solid Neoplasm | Phase 2 | Completed | Mayo Clinic | 40 | 2022-06-09 | 2026-01-16 |
| Reducing Pain and Opioid Use With CBD Cannabidiol, Placebo - Opioid Use Disorder | Phase 2 | Completed | University of Colorado, Denver | 126 | 2022-03-08 | 2025-12-12 |
Showing 20 of 54. Sign in to see all of them.
Marijuana Abuse (14) · Anxiety Disorders (4) · Opioid-Related Disorders (4) · Pain (4) · Stress Disorders, Post-Traumatic (4) · Epilepsy (3) · Alcoholism (2) · Alzheimer Disease (2) · Cognitive Dysfunction (2) · Diabetes Mellitus (2) · Multiple Sclerosis (2) · Parkinson Disease (2) · Psychotic Disorders (2) · Sturge-Weber Syndrome (2) · Arthralgia (1)
University of Colorado, Denver (5) · Jazz Pharmaceuticals (4) · Anne Comi, MD (2) · Centre hospitalier de l'Université de Montréal (CHUM) (2) · City of Hope Medical Center (2) · Hurd,Yasmin, Ph.D. (2) · Pure Green (2) · University of California, San Diego (2) · University of Virginia (2) · Aalborg University Hospital (1) · Brigham and Women's Hospital (1) · Dana-Farber Cancer Institute (1) · Hamilton Health Sciences Corporation (1) · Hartford Hospital (1) · Icahn School of Medicine at Mount Sinai (1)
United States (34) · Canada (5) · Denmark (3) · Netherlands (3) · Spain (3) · Australia (2) · Israel (2) · Sweden (2) · United Kingdom (2) · Argentina (1) · Brazil (1)
Anne M Comi, MD (2) · Debra Kimless, M.D. (2) · Brent DeGeorge, MD, PhD (1) · Brian Martis, MD (1) · Catherine R Ayers, PhD (1) · Charles Marmar, MD (1) · Didier Jutras-Aswad, MD,MS (1) · Didier Jutras-Aswad, MD,MS,FRCPC (1) · Giovanni Marotta (1) · Godfrey Pearlson, MD (1) · Ilana Braun, MD (1) · Javi Santiago (1) · Joji Suzuki, M.D. (1) · Jonathan Vela (1)
PMID 27573936, PMID 31109198, PMID 32350749, PMID 32652616, PMID 33464660, PMID 34619044, PMID 35135986, PMID 36105269, PMID 36123113, PMID 38466972, PMID 38770686, PMID 39016024, PMID 39680411, PMID 39719161, PMID 40357520, PMID 41469488, PMID 41514385, PMID 42454450
2015 (2), P30CA033572 (2), 2014 (1), R01MH139940 (1), R21DA027781 (1)